ONCOVISTA INNOVATIVE THERAPIES, INC
CIK 0001094847
Revenue (TTM)
$0
Q3 Nov 2015
Net Income (TTM)
−$1.47M
−75.5% YoY
Q3 Nov 2015
EPS Diluted (TTM)
—
Q3 Nov 2015
Gross Margin
—
Q3 Nov 2015
Operating Margin
—
Q3 Nov 2015
Net Margin
—
Q3 Nov 2015
Free Cash Flow (TTM)
−$1.56M
Q3 Nov 2015
Cash
$61.27K
Q3 Nov 2015
Total Debt
$250K
Q3 Nov 2015
Shares Outstanding
23.56M sh
Q3 Nov 2015
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.